Emerson Electric Co

EMR is undergoing a post-parabola collapse with price trading below the 9-, 20-, and 50-day EMAs amid heavy overhead supply. Medium-term bias is bearish under a Stage 4 decline, and short-term momentum remains weak. Sell execution is favored now, targeting further breakdown toward the 200-day SMA near the 143 zone unless price can decisively reclaim the 50-day SMA and 20-day EMA.

• ↑Q3 revenue of $4.87B up 7% YoY on broad-based order growth
• ↑Adjusted EPS $1.71, 13% YoY increase, beat consensus
• ↓P/E ratio 35.6× vs fair value 33.4× suggests limited upside